Maternal ADHD drug use not tied to neurodevelopmental disorders, autism in children

In utero exposure to amphetamine/dextroamphetamine or methylphenidate was not associated with increased risks for neurodevelopmental disorders in children, according to cohort study results published in JAMA Psychiatry.
“By 2013, approximately 1.2% [of pregnant individuals in the U.S.] reported ADHD medication use. Amphetamine/dextroamphetamine is by far the most commonly used stimulant medication for ADHD in adults in the U.S. followed by methylphenidate, whereas nonstimulant medications are less common,” Elizabeth A. Suarez, MPH, PhD, an instructor of epidemiology at the Center

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart